Brind.

Royal Bank of Canada increased its price objective for BeOne Medicines Ltd., while insider Lai Wang sold company stock.

1 report, 1 independent Updated Jun 11

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Royal Bank of Canada Lai Wang

Keep exploring

The entities involved

Royal Bank of Canada
financial institution in Canada
- Royal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Mon 16:02
- PrairieSky Royalty Ltd. operates in the Western Canadian Sedimentary Basin and is currently receiving research ratings from Royal Bank of Canada (RBC).Mon 09:02
Lai Wang
researcher (ORCID 0000-0001-7262-0020)

Nothing else this week.

Related events

Mizuho and Royal Bank of Canada raised price targets and gave outperform ratings for GE Vernova shares.Aug 30

Coverage

Newest first; wire copies grouped

Jun 11dailypolitical.com